Evidence map›Paper›PMID 31540221›Full record

ArticleMolecules (Basel, Switzerland)2019

Apple Peel Flavonoid Fraction 4 Suppresses Breast Cancer Cell Growth by Cytostatic and Cytotoxic Mechanisms.

Chao-Yu Loung, Wasundara Fernando, H P Vasantha Rupasinghe, David W Hoskin

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Chao-Yu LoungDepartment of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. joe.loung@dal.ca.
Wasundara FernandoDepartment of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. wasufer@dal.ca.
H P Vasantha RupasingheDepartment of Pathology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada.ORCID 0000-0003-3435-0052
David W HoskinDepartment of Pathology, Department of Microbiology and Immunology, Department of Surgery, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada. d.w.hoskin@dal.ca.
Dalhousie University · CA

Funding

Canadian Cancer Society/Canadian Breast Cancer Foundation NANatural Sciences and Engineering Research Council of Canada NA
6 · The paper itself

Abstract

Many dietary flavonoids possess anti-cancer activities. Here, the effect of apple peel flavonoid fraction 4 (AF4) on the growth of triple-negative (MDA-MB-231, MDA-MB-468), estrogen receptor-positive (MCF-7), and HER2-positive (SKBR3) breast cancer cells was determined and compared with the effect of AF4 on normal mammary epithelial cells and dermal fibroblasts. AF4 inhibited breast cancer cell growth in monolayer cultures, as well as the growth of MCF-7 spheroids, without substantially affecting the viability of non-malignant cells. A sub-cytotoxic concentration of AF4 suppressed the proliferation of MDA-MB-231 cells by inhibiting passage through the G

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBreast NeoplasmsCell Line, TumorCell ProliferationCell SurvivalErb-b2 Receptor Tyrosine KinasesFemaleFlavonoidsHumansMalusMCF-7 CellsMiceReceptors, EstrogenXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesFlavonoidsReceptors, Estrogenapoptosisbreast cancercell cycleflavonoidsreactive oxygen speciestumor suppression

Identifiers

PMID31540221
PMCPMC6766994
OpenAlexW2972493228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.